By Published On: May 5, 2022

ENT & Allergy Deal Activity Cools Off to Begin 2022 Look For Additional PE Investor Interest Ahead

The first quarter of 2022 delivered two reported ENT practice acquisitions, coming down from a flurry of deal activity to end last year.

DOWNLOAD TO READ MORE

Andy Snyder has worked on mergers and acquisitions, capital raises, and strategic advisory assignments for a wide range of healthcare companies. His current practice includes healthcare provider services, behavioral health, healthcare facilities, healthcare IT, and medical technology.